$ZBH Zimmer Biomet Holdings, Inc.

What Do They Do?

Sells orthopedic implants, surgical products, and robotic and digital technologies to healthcare institutions, clinicians, and distributors.

Who Are Their Customers?

The company sells directly to hospitals and ambulatory surgery centers and through stocking distributors and healthcare dealers; purchasing organizations and buying groups act as agents.

How Are They Changing?

Since the FY2025 annual report

Latest quarter: Q2 FY2026, the three months to Jun 30, 2026

Revenue: ▲ +5%; vs $2.1B in Q2 FY2025
Net income: ▲ +30%; vs $152.8M in Q2 FY2025

Knees share of revenue vs 39.8% in Q2 FY2025

Aug 5, 2026 Raised full-year revenue growth guidance The 2026 reported revenue growth range increased to 3.9%–4.9%.
Apr 28, 2026 CFO departed; interim successor appointed Paul Stellato became interim CFO while the company searches for a permanent successor.

Revenue over time

Knees Hips S.E.T Technology & Data, Bone Cement and Surgical Other

$10B$5B$0

FY2021 FY2022 FY2023 FY2024 FY2025

Who Do They Compete With?

Competes with Johnson & Johnson MedTech, Stryker, and Smith & Nephew